OOL Vaccines for the Prevention of Cervical Cancer
Guest Access | Sign In

OOL Vaccines for the Prevention of Cervical Cancer

Oxford Medicine Online
 

Chapter 1 The UK cervical screening programme

Karin Denton

  • • The Cervical Screening Programme (CSP) in the United Kingdom is fully integrated across the lifetime of a woman and across all clinical disciplines.
  • • Cervical screening is estimated to prevent up to 80% of all cases of cervical cancer in the United Kingdom.
  • • All aspects of the programme are defined by published specifications and standards.
  • • The programme has high population coverage and is rigorously quality assured.
  • • Liquid-Based Cytology (LBC) implementation will be complete in 2008.
  • • Maintaining the protection currently offered by cervical screening while new technologies are implemented will be a challenge, but can be achieved.






DOI: 10.1093/med/9780199543458.003.0001

This practical online reference provides an overview of the role of HPV in the pathology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the challenges of implementing HPV vaccines and future developments.

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work.

Related OUP Products
Oxford Handbook of Oncology The Cancer Prevention Manual
Oxford Journals: latest research